Guardian Pharmacy Services Inc(GRDN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 10 at 4:00 PM ET (Korea 11/11 06:00)AI-drawn chart patterns are for reference only.
Full metrics table
| Index | RUT | P/E | 42.52 | EPS (ttm) | 1.17 | Insider Own | 57.71% | Shs Outstand | 63.3M | Perf Week | 21.97% |
| Market Cap | 3.16B | Forward P/E | 33.81 | EPS next Y | 9.32% | Insider Trans | - | Shs Float | 21.1M | Perf Month | 23.18% |
| Enterprise Value | 3.09B | PEG | 2.2 | EPS next Q | 0.44 | Inst Own | 59.76% | Short Float | 11.31% | Perf Quarter | 29.21% |
| Income | 0.07B | P/S | 2.17 | EPS this Y | 26.03% | Inst Trans | 1.28% | Short Ratio | 4.56 | Perf Half Y | 42.8% |
| Sales | 1.46B | P/B | 11.82 | EPS next 5Y | 15.34% | ROA | 16.96% | Short Interest | 2.38M | Perf YTD | 65.67% |
| Book/sh | 4.22 | P/C | 26.39 | EPS past 3/5Y | 10.88% 31.17% | ROE | 33.16% | 52W High | 3.15% ($48.33) | Perf Year | 67.56% |
| Cash/sh | 1.89 | P/FCF | 32.83 | Sales past 3/5Y | 16.81% 16.29% | ROIC | 25.33% | 52W Low | 89.26% ($26.34) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | 26.65 | EPS Y/Y TTM | 83.17% | Gross Margin | 22.45% | Volatility(W/M) | 7.25% 4.31% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 2.12 | Sales Y/Y TTM | 4.85% | Oper. Margin | 6.34% | ATR (14) | 2.1 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.33 | EPS Q/Q | 88.82% | Profit Margin | 5.13% | RSI (14) | 73.01 | Recom | 1.14 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.65 | Sales Q/Q | -1.68% | SMA20 | 21.28% ($41.1) | Beta | 0 | Target Price | $50.14 |
| Payout | - | Debt/Eq | 0.13 | Earnings | 2026/11/5 | SMA50 | 19.09% ($41.86) | Rel Volume | 2.27 | Prev Close | $47.02 |
| Employees | 3600 | LT Debt/Eq | 0.1 | EPS/Sales Surpr. | 4.9% 1.45% | SMA200 | 29.27% ($38.56) | Avg Volume(3M) | 0.52M | Price | $49.85 |
| IPO | 2024/9/26 | Option/Short | Yes/Yes | Trades | 11974 | Volume | 1,184,600 | Change | 6.02% |
💊 This is a US healthcare services company that provides long-term care pharmacy services. It offers prescription dispensing and medication management services to senior living and long-term care facilities, with exposure to the aging population and prescription volume. The company operates in the long-term care pharmacy sector.
Over the past 1 year, on the higher side
0% below its 1-year high.
Traded more than usual. That is 227% of its average volume.
GRDN makes money exceptionally well
Of every $100 in sales, $6.34 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +26.0% this year.
Tap to view numbers
However, it looks expensive
Counting its debt, for $100 of yearly operating cash you would pay $2,665. Peers typically go for $1,226.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 5 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership is about average
Institutions hold 59.8%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #16 of 48 in the industry
Based on market cap of $3B.
ACHC#13 Acadia Healthcare Company Inc $4B PER - 
SGRY#14 Surgery Partners Inc $3B PER - 
NHC#15 National Healthcare Corp $3B PER 28.8 GRDN#16 Guardian Pharmacy Services Inc $3B PER 42.5 
AVAH#17 Aveanna Healthcare Holdings Inc $3B PER 10.7 
FAQ
What kind of company is GRDN?
GRDN belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of GRDN?
The market cap of GRDN is approximately $3.2B, ranking 1,721 within its sector.
What is the P/E ratio of GRDN?
GRDN has a P/E ratio of approximately 42.5x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for GRDN?
GRDN has recorded a 52-week high of $48.33 and a low of $26.34.
